Geodesic
Could changes in national tuberculosis vaccination policies be ill-informed ?
D.J. Gerberry1 ; F.A. Milner2
1 Department of Mathematics and Computer Science, Xavier University, 3800 Victory Parkway, Cincinnati, Ohio 45207, USA
2 School of Mathematical and Statistical Sciences, Arizona State University, P.O. Box 871804, Tempe, Arizona 85287, USA
Mathematical modelling of natural phenomena, Tome 7 (2012) no. 3, pp. 78-98 Cet article a éte moissonné depuis la source EDP Sciences

Voir la notice de l'article

National policies regarding the BCG vaccine for tuberculosis vary greatly throughout the international community and several countries are currently considering discontinuing universal vaccination. Detractors of BCG point to its uncertain effectiveness and its interference with the detection and treatment of latent tuberculosis infection (LTBI). In order to quantify the trade-off between vaccination and treatment of LTBI, a mathematical model was designed and calibrated to data from Brazil, Ghana, Germany, India, Mexico, Romania, the United Kingdom and the United States. Country-specific thresholds for when LTBI treatment outperforms mass vaccination were found and the consequences of policy changes were estimated. Our results suggest that vaccination outperforms LTBI treatment in all settings but with greatly reduced efficiency in low incidence countries. While national policy statements emphasize BCG’s interference with LTBI detection, we find that reinfection should be more determinant of a country’s proper policy choice.
DOI : 10.1051/mmnp/20127307

D.J. Gerberry 1 ; F.A. Milner 2

1 Department of Mathematics and Computer Science, Xavier University, 3800 Victory Parkway, Cincinnati, Ohio 45207, USA
2 School of Mathematical and Statistical Sciences, Arizona State University, P.O. Box 871804, Tempe, Arizona 85287, USA 
@article{10_1051_mmnp_20127307,
     author = {D.J. Gerberry and F.A. Milner},
     title = {Could changes in national tuberculosis vaccination policies be ill-informed\,?},
     journal = {Mathematical modelling of natural phenomena},
     pages = {78--98},
     year = {2012},
     volume = {7},
     number = {3},
     doi = {10.1051/mmnp/20127307},
     language = {en},
     url = {http://geodesic.mathdoc.fr/articles/10.1051/mmnp/20127307/}
}
TY  - JOUR
AU  - D.J. Gerberry
AU  - F.A. Milner
TI  - Could changes in national tuberculosis vaccination policies be ill-informed ?
JO  - Mathematical modelling of natural phenomena
PY  - 2012
SP  - 78
EP  - 98
VL  - 7
IS  - 3
UR  - http://geodesic.mathdoc.fr/articles/10.1051/mmnp/20127307/
DO  - 10.1051/mmnp/20127307
LA  - en
ID  - 10_1051_mmnp_20127307
ER  - 
%0 Journal Article
%A D.J. Gerberry
%A F.A. Milner
%T Could changes in national tuberculosis vaccination policies be ill-informed ?
%J Mathematical modelling of natural phenomena
%D 2012
%P 78-98
%V 7
%N 3
%U http://geodesic.mathdoc.fr/articles/10.1051/mmnp/20127307/
%R 10.1051/mmnp/20127307
%G en
%F 10_1051_mmnp_20127307
D.J. Gerberry; F.A. Milner. Could changes in national tuberculosis vaccination policies be ill-informed ?. Mathematical modelling of natural phenomena, Tome 7 (2012) no. 3, pp. 78-98. doi: 10.1051/mmnp/20127307

[1] Centers for Disease Control and Prevention. TB Elimination : Treatment of Latent Tuberculosis Infection (LTBI) July 2007. Accessed March 25, 2009 from : http://cdc.gov/TB/pubs/tbfactsheets/treatmentLTBI.pdf

[2] World Health Organization. WHO position paper on BCG vaccination. Weekly Epidemiological Record, 79(4) :27–38, January 2004. Accessed on May 5, 2008 from : http://www.who.int/wer

[3] Centers for Disease Control and Prevention. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. Morbidity and Mortality Weekly Report : Recommendations and Reports, 45(RR-4), 1996.

[4] World Health Organization. Global Tuberculosis Database, 2008. Accessed March 12, 2009 from : http://www.who.int/tb/country/global_tb_database/en/

[5] World Health Organization, Department of Immunization, Vaccines and Biologicals. WHO vaccine-preventable diseases : monitoring system. 2007 Global Summary, 2007. Accessed on March 12, 2009 from : http://whqlibdoc.who.int/hq/2007/who_ivb_2007_eng.pdf

[6] United States Census Bureau, Population Division. International Data Base, Decemeber 15, 2008. Accessed Jan 9, 2009 from http://www.census.gov/ipc/www/idb/index.html

[7] E. Ziv, C.L. Daley, S.M. Blower Potential public health impact of new tuberculosis vaccines 1529 1535 2004

[8] Ted Cohen, Caroline Colijn, Bryson Finklea, Megan Murray Exogenous re-infection and the dynamics of tuberculosis epidemics : local effects in a network model for transmission 523 531 2007

[9] P.G. Smith and A.R. Moss. Tuberculosis : Pathogenesis, Protection, and Control, chapter Epidemiology of tuberculosis. ASM Press, 1994.

[10] D. Smith, E. Wiegeshaus, V. Balasubramanian An analysis of some hypothesis related to the Chingelput Bacille Calmette-Guérin trial S77 80 2000

[11] M.G.M. Gomes, A.O. Franco, M.C. Gomes, G.F. Medley The reinfection threshold promotes variability in tuberculosis epidemiology and vaccine efficay 617 623 2004

[12] D. Menzies What does tuberculin reactivity after Bacille Calmette-Guèrin vaccination tell us ? S71 4 2000

[13] R.I. Menzies, B. Vissandjee Effect of Bacille Calmette-Guérin vaccination on tuberculin reactivity 621 5 1992

[14] Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. Morbidity and Mortality Weekly Report : Recommendations and Reports, 49(RR-6) :1–54, 2000.

[15] F. Ma. Cecilia García-Sancho, Lourdes García-García, Ma. Eugenia Jiménez-Corona, Manuel Palacios-Martínez, Leticia D. Ferreyra-Reyes, Sergio Canizales-Quintero, Bulmaro Cano-Arellano, Alfredo Ponce De León, José Sifuentes-Osornio, Peter Small, Kathryn Deriemer Is tuberculin skin testing useful to diagnose latent tuberculosis in BCG-vaccinated children ? 1447 1454 2006

[16] S. Gryzbowski, G.D. Barnett, K Styblo Contact case of active pulmonary tuberculosis 90 106 1975

[17] T.J. Joos, W.C. Miller, D.M. Murdoch Tuberculin reactivity in bacille Calmette-Guérin vaccinated populations : a compilation of international data 883 91 2006

[18] D.-L. Ling, Y.-P. Liaw, C.-Y. Lee, H.-Y. Lo, H.-L. Yang, P.-C. Chan Contact investigation for tuberculosis in taiwan contacts aged under 20 years in 2005 50 5 2011

[19] P. Musoke Mudido, D. Guwatudde, M.K. Nakakeeto, G.B. Bukenya, D. Nsamba, J.L. Johnson, R.D. Mugerwa, J.J. Ellner, C.C. Whalen The effect of bacille Calmette-Guérin vaccination at birth of tuberculin skin test reactivity in Ugandan children 891 895 1999

[20] Ibrahim O Al-Orainey Diagnosis of latent tuberculosis : Can we do better ? 5 9 2009

[21] Ajit Lalvani, Manish Pareek A 100 year update on diagnosis of tuberculosis infection 69 84 2010

[22] O. Oxlade, K. Schwartzman, D. Menzies Interferon-gamma release assays and tb screening in high-income countries : a cost-effectiveness analysis 16 26 2007

[23] S. Verver, R.M. Warren, N. Beyers, M. Richardson, G.D. Van Der Spuy, M.W. Borgdorff, D.A. Enarson, M.A. Behr, P.D. Helden Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis 1324 5 2005

[24] Centers for Disease Control and Prevention. Reported Tuberculosis in the United States, 2007. Atlanta, GA, September 2008.

[25] D.J. Gerberry Trade-off between bcg vaccination and the ability to detect and treat latent tuberculosis 548 60 2009

[26] G.W. Comstock, V.T. Livesay, S.F. Woolpert The prognosis of a positive tuberculin reaction in childhood and adolescence 131 8 1974

[27] Thomas R. Frieden, Timothy R. Sterling, Sonal S. Munsiff, Catherine J. Watt, Christopher Dye Tuberculosis 887 899 2003

[28] Douglas Young, Christopher Dye The development and impact of tuberculosis vaccines 683 687 2006

[29] S.M. Blower, A.R. Mclean, T.C. Porco, P.M. Small, P.C. Hopewell, M.A. Sanchez, A.R. Moss The intrinsic transmission dynamics of tuberculosis epidemics 815 821 1995

[30] T.C. Porco, S.M. Blower Quantifying the intrinsic transmission dynamics of tuberculosis epidemics 117 132 1998

[31] Mayo Foundation for Medical Education and Research. Tuberculosis, Jan 28, 2009. Accessed May 21, 2009 from : http://www.mayoclinic.com/health/tuberculosis/DS00372/

[32] N.E. Aronson, M. Santosham, G.W. Comstock, R.S. Howard, L.H. Moulton, E.R. Rhoades, L.H. Harrison Long-term efficacy of BCG vaccine in American Indians and Alaska Natives : A 60-year follow-up study 2086 2091 2004

[33] J.A.C. Sterne, L.C. Rodrigues, I.N. Guedes Does the efficacy of BCG decline with time since vaccination ? 200 207 1998

[34] Christopher Dye, Geoffrey P. Garnett, Karen Sleeman, Brian G. Williams Prospects for worldwide tuberculosis control under the WHO DOTS strategy 1886 1891 1998

[35] Christopher Dye, Suzanne Scheele, Paul Dolin, Vikram Pathania, Mario C. Raviglione Global burden of tuberculosis : Estimated incidence, prevalence, and mortality by country 677 686 1999

[36] World Health Organization. Tuberculosis factsheet No. 104, March 2007. Accessed May 10, 2009 from : http://www.who.int/mediacentre/factsheets/fs104/en/index.html

[37] Diane E. Bennett, Jeanne M. Courval, Ida Onorato, Tracy Agerton, Judy D. Gibson, Lauren Lambert, Geraldine M. Mcquillan, Brenda Lewis, Thomas R. Navin, Kenneth G. Castro Prevalence of tuberculosis infection in the United States population 348 355 2008

[38] Timothy R. Sterling, James Bethel, Stefan Goldberg, Paul Weinfurter, Lourdes Yun, C. Robert Horsburgh The scope and and impact of treatment of latent tuberculosis infection in the United States and Canada 927 931 2006

[39] Anneke C Hesseling, Ben J Marais, Robert P Gie, H Simon Schaaf, Paul E M Fine, Peter Godfrey-Faussett, Nulda Beyers The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children 14 8 2007

[40] World Health Organization. Revised BCG vaccination guidelines for children with HIV infection. pages 1–4, Apr 2007.

[41] G. Elzinga, M.C. Raviglione, D. Maher Scale up : meeting targets in global tuberculosis control 814 819 2004

Cité par Sources :